Heidi Cuthbert

SOPHiA GENETICS (NASDAQ:SOPH) reported a record-breaking performance for 2025, driven by a surge in demand for its AI-powered genomic analysis, as the company prepares for a major leadership transition and moves closer to profitability.

Zymeworks (NASDAQ:ZYME), a clinical-stage biotechnology company developing novel, bispecific antibody therapeutics, provided a strategic update outlining key priorities for 2026, anchored by recent clinical and regulatory progress for its lead candidate Ziihera (zanidatamab-hrii).

Monero has reached a record high, with traders drawing comparisons to silver’s explosive breakout pattern.

Malaysia and Indonesia have banned the Grok AI chatbot over concerns it can generate harmful sexually explicit deepfakes.

Britain has settled a torture complicity case with Guantanamo detainee Abu Zubaydah through a substantial compensation payment.

The latest jobs report confirms 2025 was the weakest year for US hiring since 2003.

Tennessee has moved to block prediction market platforms from offering sports contracts to residents.

Chinese camera maker Insta360 is stepping up its US drone push as regulators tighten curbs on rival manufacturers.

USANA Health Sciences (NYSE:USNA), a global leader in nutritional supplements and wellness products sold through direct selling, today announced preliminary fiscal year 2025 net sales results and its initial net sales outlook for fiscal 2026 ahead of its presentation at the 28th Annual ICR Conference.

More than 544,000 accounts have been removed from Facebook, Instagram, and Threads following Australia's new ban on under-16s using social media.